EMvision Medical Devices Limited (ASX: EMV) - Share Price

Current share price for EMV : $1.510 0.01 (0.67%)⁺

EMVision Medical Devices Limited (EMV), an ASX-listed company, is an Australian medical device company developing a novel approach to looking inside the human body. Its product pipeline includes portable, non-invasive, non-ionizing, affordable and safe neurodiagnostic devices.

EMV General Information ⁺

ASX Code	EMV
Website	http://www.emvision.com.au
Industry/Sector	Health Care Equipment
Market Cap ($M)	140
EMV Share Price	$1.510
Day High	$1.510
Day Low	$1.500
Last Close	$1.500
EMV Share Price Movement	$0.01 ( 0.67% )

Prices as at 16:40, 9 Jul 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

EMvision Medical Devices Limited (EMV) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from EMvision Medical Devices Limited (EMV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EMvision Medical Devices Limited (EMV) price-sensitive announcements

EMV - Aeromedical Study De-Risks Rural & Remote Stroke Use Cases

EMVision Medical Devices Limited announced successful completion of a study on the feasibi

EMvision Medical Devices Limited (EMV)
27 May 2026 | 8:40 AM

EMV - EMVision to Receive $1.17M IGP Grant Instalment

EMVision Medical Devices Limited announced it will receive a $1.17 million instalment from

EMvision Medical Devices Limited (EMV)
25 May 2026 | 8:20 AM

EMV - emu Pivotal Trial Expansion Adds Acute Ischaemia Detection

EMVision Medical Devices Limited has announced the expansion of its emu™ Pivotal (Validati

EMvision Medical Devices Limited (EMV)
11 May 2026 | 8:27 AM

EMV - Quarterly Activities/Appendix 4C Cash Flow Report

EMVision Medical Devices Limited, an Australian company, has released its Quarterly Activi

EMvision Medical Devices Limited (EMV)
13 Apr 2026 | 9:04 AM

EMvision Medical Devices Limited (EMV) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	Aeromedical Study De-Risks Rural & Remote Stroke Use Cases	27 May 2026 8:40AM	$1.710	$1.510	fallen by 11.70%
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	EMVision to Receive $1.17M IGP Grant Instalment	25 May 2026 8:20AM	$1.670	$1.510	fallen by 9.58%
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	Cleansing Notice	12 May 2026 9:47AM	$1.890	$1.510	fallen by 20.11%
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	Application for quotation of securities - EMV	12 May 2026 9:42AM	$1.890	$1.510	fallen by 20.11%
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	emu Pivotal Trial Expansion Adds Acute Ischaemia Detection	11 May 2026 8:27AM	$1.908	$1.510	fallen by 20.84%
EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID	Health Care	$140	Change of Director's Interest Notice	24 Apr 2026 9:33AM	$1.815	$1.510	fallen by 16.80%

EMV Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$9.81	-$11.50	238.60%	0.00%	0.0%
2024A	-$2.73	-$3.40	-31.90%	0.00%	0.0%
2023A	-$3.87	-$5.00	-38.70%	0.00%	0.0%

EMV Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
Cochlear Limited (COH)	$8,309M	0.0171	-0.1883	0.0862	21.2306	26.1554	24.0807	3.38%	2.73%	2.91%
EMvision Medical Devices Limited (EMV)	$144M	2.3864	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$19,669M	0.1388	0.1335	0.1884	50.6427	44.6772	37.5954	1.29%	1.38%	1.56%
ResMed Inc. (RMD)	$18,675M	0.3087	9.7641	0.0805	216.2311	20.0882	18.5914	1.06%	1.12%	1.18%

EMV Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	13.80	0.00
Market	0.28	13.00	1.14	0.58
Sector	0.68	23.20	1.59	2.54

EMV Directors

Name	Position	Start Date
Mr Scott Kirkland	Co-founder, Executive Director, Chief Executive Officer, Managing Director	11 Jul 2017
Mr John Keep	Non-Executive Chairman, Non-Executive Director	2 Mar 2018
Dr Phillip James Dubois	Non-Executive Director	29 Sep 2020
Mr Anthony (Tony) Keane	Non-Executive Director	29 Jun 2018
Mr Patryk Kania	Non-Executive Director	7 Mar 2024
Ms Carmel Anne Monaghan	Non-Executive Director	5 Jun 2025

EMvision Medical Devices Limited (EMV) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
22 Apr 2026	MONAGHAN, Carmel	Buy	Direct Shares	10,000	$1.847	$18,470.000
5 May 2023	WEINBERGER, Ronald (Ron)	Exercise	Options	223,602	$5.590	$1,250,000.000
5 May 2023	WEINBERGER, Ronald (Ron)	Buy	Direct Shares	223,602	$5.590	$1,250,000.000

See all changes in directors' interest & trades for EMvision Medical Devices Limited (EMV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EMV Management

Name	Position
Emma Waldon	Company Secretary

EMV Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EMvision Medical Devices Limited (EMV). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
7,454,231 (8.72%)	Keysight Technologies, Inc
4,276,987 (5%)	Scott Kirkland

EMV Calendar of Events

Date	Event
22 February 2027	Report (Interim)
27 August 2026	Report (Annual)
27 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us